Interstitial Lung Diseases
33
7
11
11
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 33 trials
100.0%
+13.5% vs benchmark
9%
3 trials in Phase 3/4
9%
1 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (33)
Efficacy and Safety of Golidocitinib for Rapidly Progressive Interstitial Lung Disease
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
The Effects of Whole-Body Vibration Training on Clinical and Functional Outcomes in Individuals Diagnosed With Interstitial Lung Disease
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
Anlotinib Capsules in the Treatment for IPF/PF-ILDs
Ultrasound and Respiratory Physiological Signals in Lung Diseases
Clinical Outcomes and Immunotherapy in Lung Cancer With Pulmonary Fibrosis
Interstitial Lung Disease: A Study From Infancy to Elderly Including Relatives
Optimizing and Standardizing 129Xe Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease
Advanced Mutidimensional and Ultra High Resolution Computed Tomography to Inspect Cardiopulmonary Involvement in Progressive Fibrosing Interstitial Lung Diseases
A Study Using a Disease Registry to Observe the Long-term Effects of Nintedanib in People With Scleroderma-related Lung Fibrosis
Bronchoalveolar Lavage in Interstitial Lung Diseases to Characterization of Specific Inflammatory Cellular Infiltrate in Different Interstitial Lung Diseases
Interstitial Lung Diseases in Respiratory ICU
Breath Analysis and Arterial Stiffness in Patients With Respiratory Diseases
LetS Get fUnctional! FuNctional Status in pEople With intersTitial Lung Disease
Clinical Course of Interstitial Lung Diseases: European IPF Registry and Biobank
Autologous Lung Stem Cell Transplantation in Patients With Interstitial Lung Diseases
Can we Reduce Hospital Attendance Without Compromising Care by the Use of Telephone Consultation